This test is most useful if any of these apply to you.
If you have unexplained fatigue, brain fog, or symptoms you trace back to a water-damaged home or office, this test looks for a specific mold-made toxin in your urine. It is one way to ask whether your body has recently crossed paths with the mold Aspergillus fumigatus.
This is a research-stage measurement, not a settled clinical test. There are no standardized normal ranges, so treat a single number as one clue rather than a verdict.
Gliotoxin is a mycotoxin, meaning a toxin made by molds rather than by your own body. Roughly 90 percent of it comes from a single species, Aspergillus fumigatus, a common mold found in soil, decaying plant material, and damp indoor spaces.
Chemically, gliotoxin carries a reactive sulfur bridge that lets it latch onto proteins and generate unstable oxygen molecules that damage cells (called reactive oxygen species). That same chemistry is what makes it biologically active, and it is why the molecule interests researchers even though it plays no normal role in human biology.
The reason gliotoxin draws attention is its effect on immune cells. In laboratory and animal studies, it interferes with the cells that patrol for invaders, including the large cells that engulf debris (macrophages) and the first-responder white blood cells (neutrophils), and it can blunt the activity of the immune cells that coordinate longer-term defense.
These findings come from cell and animal experiments, not from studies measuring urine gliotoxin in people, so they explain why the molecule matters rather than proving what your specific level does to your immunity. A detectable amount is best read as a marker of possible mold activity, not as a diagnosis of immune suppression.
Most human research on gliotoxin has nothing to do with urine. It has focused on blood and lung-fluid samples in seriously ill patients with invasive aspergillosis, a dangerous lung or bloodstream infection that mostly strikes people with weakened immune systems.
Even in that setting, the toxin has been an unreliable signal. Gliotoxin and its more stable chemical relative bmGT (bis(methylthio)gliotoxin) were often undetectable in the blood of patients with confirmed infection, and researchers concluded they are not dependable tests, favoring better-established markers instead.
One study reported bmGT as more sensitive than the standard mold sugar test called galactomannan, while others found it negative in every infected patient they checked. That apparent contradiction is not a paradox: gliotoxin production varies by fungal strain, host immune state, and which body fluid is sampled, so the same toxin can look present or absent depending on conditions. None of this blood-and-lung work translates directly to what a urine result means for you.
Direct human data on urine gliotoxin is scarce. One study measured a panel of mold toxins, including gliotoxin, in the urine of children with autism and compared them with unrelated healthy children. The clear statistical difference in that study was for a different mold toxin, ochratoxin A, not gliotoxin, and a separate pilot study found no association between urinary mold toxins and autism at all.
The study did report urine gliotoxin values in children, but the authors were clear about the limits: no reference values existed to compare against, the group was small, and the work does not show that gliotoxin causes anything. It is a starting point for research, not a basis for interpreting your own number against a known cutoff.
A urine mycotoxin measurement generally reflects recent exposure rather than a lifetime accumulation, because water-soluble toxins are cleared through the kidneys over hours to days. The exact clearance speed for gliotoxin in humans has not been established, which is another reason a single snapshot can mislead.
Levels also swing with how dilute your urine is and how much water you drank before collecting. That biological noise is exactly why a trend beats a single value. A useful pattern is a baseline test, a repeat test a few weeks to a couple of months later if you change your environment, and periodic rechecks after that, so you are comparing your own readings over time rather than chasing an unvalidated threshold.
Because there are no agreed reference ranges, the biggest trap is over-reading a single number. It also helps to know that medical toxicology groups caution that the dose of mold toxins inhaled in typical damp buildings is generally far below levels shown to cause harm, and that finding a mold toxin in urine cannot by itself be pinned to inhaled exposure. Beyond that, a few practical factors can distort a reading:
A detectable or higher-than-your-baseline result is a reason to look at your environment, not to panic. The most productive next step is investigating your home and workplace for water damage or visible mold, since source control is where the real leverage sits.
Because this marker is exploratory, interpret it alongside the bigger picture rather than in isolation. A result that lines up with real symptoms and a known damp-building exposure is more meaningful than an isolated number in a person who feels well. Running a broader urine mycotoxin panel can show whether gliotoxin appears alone or with other mold toxins, though keep in mind that no validated framework links these urine levels to specific symptoms.
If your level is elevated and you have persistent symptoms, or if you are immunocompromised, bring the result to a clinician or toxicologist who can weigh your exposure history and decide whether further evaluation is warranted. Avoid self-directed chelation or commercial detox protocols, which have not been shown to lower urine gliotoxin or reduce any harm from it.
Gliotoxin is best interpreted alongside these tests.
Gliotoxin is included in these pre-built panels.